Mode of action |
Effect |
Research phase |
System for experiment |
Reference |
EGCG target virus/host cells protein |
1. Inhibits GRP78 receptor and makes it accumulate in ER rather than on cell membrane |
Preclinical study (in vivo & in vitro) |
Nervous system diseases (MME cells, Ren cells) |
(Martinotti, Ranzato, & Burlando, 2018) |
2. Inhibits GRP78 expression by enhancing mir‐155‐5p level |
Preclinical study |
Colon cancer (HCT116) |
(La, Zhang, Li, Li, & Yang, 2019) |
3. Inhibits the binding of S‐spike protein to ACE2 receptor and effectively blocks the infection of SARS‐COV‐2 and new variants |
Preclinical study |
SARS‐CoV‐2 and its variants with D614G, K417N, E484K, and N501Y mutation) |
(Liu et al., 2021) |
4. Targets to inhibit 3CLpro |
Preclinical study (in vitro) |
SARS‐CoV‐2 |
(Zhu & Xie, 2020) |
Regulate immune level |
Via TLR4/MyD88/NF‐κB signaling pathway, EGCG maintains Th1/Th2 balance and reduces inflammatory factors
|
Preclinical study (animal level) |
Ulcerative colitis rat model |
(Xue, Liu, Dong, Liang, & Chen, 2017) |
2. Increases lymphocytosis and shows a reduction in the absolute number of circulating Treg, and serum IL‐10 and TGF‐β d |
Clinical study |
12 CLL patients and 12 healthy person as control |
(Most et al., 2018) |
|
Clinical study |
Overweight women |
(Cialdella‐Kam et al., 2016) |
Inhibits cytokine storm |
Reduces the lung severity and TNF‐α, elevation of MIP‐2 and neutrophils in mice induced by LPS
|
Preclinical study (animal level) |
Lipopolysaccharide‐induced acute lung injury model in mice |
(Bae et al., 2010
)
|
|
Preclinical study (animal level) |
Lung injury in thermal injury rat model |
(Liu et al., 2017) |
-
3
Significantly inhibits radiation‐induced pulmonary fibrosis, activates Nrf‐2, and regulates serum level of TGF‐β1, IL‐6, IL‐10, and TNF‐α
|
Preclinical study (animal level) |
Pulmonary fibrosis (radiation‐induced pulmonary fibrosis rat model) |
(You et al., 2014) |
Broad‐spectrum antivirus function |
EGCG has a broad spectrum of antiviral activities against RNA viruses such as HIV, HCV, human immunodeficiency virus, Ebola virus, influenza virus, and respiratory virus |
Clinical study (animal level) |
HIV and HCV |
(Halegoua‐De Marzio et al., 2012; Shiha, Soliman, Elbasiony, Darwish, & Mousa, 2019) |